| ²é¿´: 531 | »Ø¸´: 3 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
781934544гæ (³õÈëÎÄ̳)
|
[ÇóÖú]
°ï·ÒëÏÂÕâ¶Î£¬Ð»Ð»
|
||
|
This report describes the development and scale up of the synthesis of oxaisoxazolidinone 1, a significant synthon in the synthesis of the MRSA development compound AZD5847. Studies were carried out to ensure a short-term, risk based preparation of 9 on a 5 L scale with a solid isolation procedure and a safe, long-term manufacturing process for both 1 and 9 through extensive hazards evaluation. ·¢×ÔСľ³æIOS¿Í»§¶Ë |
» ²ÂÄãϲ»¶
288Çóµ÷¼Á£¬Ò»Ö¾Ô¸»ªÄÏÀí¹¤´óѧ071005
ÒѾÓÐ7È˻ظ´
304Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
Ò»Ö¾Ô¸211£¬»¯Ñ§310·Ö£¬±¾¿ÆÖصãË«·Ç£¬Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
293µ÷¼Á
ÒѾÓÐ7È˻ظ´
327Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
307Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
283·ÖÇóµ÷¼Á
ÒѾÓÐ14È˻ظ´
Ò»Ö¾Ô¸211£¬0703»¯Ñ§305·ÖÇóµ÷¼Á
ÒѾÓÐ16È˻ظ´
»·¾³×¨Ë¶µ÷¼Á
ÒѾÓÐ13È˻ظ´
338Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
ÂçÂçÒÀÈ»
°æÖ÷ (ÖªÃû×÷¼Ò)
- ·ÒëEPI: 9
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ¹ó±ö: 21.943
- ½ð±Ò: 101714
- É¢½ð: 7049
- ºì»¨: 140
- ɳ·¢: 17
- Ìû×Ó: 5942
- ÔÚÏß: 2657.9Сʱ
- ³æºÅ: 2025515
- ×¢²á: 2012-09-24
- ÐÔ±ð: MM
- רҵ: »·¾³·ÖÎö»¯Ñ§
- ¹ÜϽ: ÎÄÏ×ÇóÖú
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
781934544: ½ð±Ò+10 2016-01-12 19:35:08
781934544: ½ð±Ò+10 2016-01-12 19:35:08
| Õâ·Ý±¨¸æÃèÊöÁË·¢Õ¹·Å´óoxaisoxazolidinone 1µÄºÏ³É£¬ËüÊÇÒ»ÖÖÖØÒªµÄºÏ³ÉÏËάÔÚ ÓÉMRSAºÏ³É»¯ºÏÎï AZD5847¹ý³ÌÖС£Ñо¿±íÃ÷£¬ÎªÈ·±£¶ÌÆÚ·çÏÕ£¬9µÄÖÆ±¸ÔÚ5L¹ÌÌå·ÖÀë³ÌÐòÖнøÐС£¶ÔÓÚ1Óë9µÄ³¤ÆÚÖÆÔì¹ý³ÌӦͨ¹ý´óÁ¿Î£ÏÕÆÀ¹À¡£ |

4Â¥2016-01-12 10:52:46
781934544
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 507
- Ìû×Ó: 40
- ÔÚÏß: 3.2Сʱ
- ³æºÅ: 4196389
- ×¢²á: 2015-11-04
- רҵ: Ò©Àíѧ
2Â¥2016-01-11 13:21:59
3Â¥2016-01-12 08:39:53














»Ø¸´´ËÂ¥